Hood River Capital Management LLC Rhythm Pharmaceuticals, Inc. Transaction History
Hood River Capital Management LLC
- $5.4 Billion
- Q3 2024
A detailed history of Hood River Capital Management LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 614,598 shares of RYTM stock, worth $36.8 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
614,598Holding current value
$36.8 Million% of portfolio
0.6%Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
192Shares Held
67.3MCall Options Held
834KPut Options Held
78.6K-
Primecap Management CO Pasadena, CA7.22MShares$432 Million0.28% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$404 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$383 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$364 Million4.44% of portfolio
-
Goldman Sachs Group Inc New York, NY3.88MShares$232 Million0.03% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.34B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...